News About: Pharm. Industry
Dong-A Socio Holdings first adopts blind recruiting method in pharma industryIn order to spread the fair recruiting culture focusing on abilities without any prejudice, Dong-A Socio Group will lead the way.
Dong-A Socio Holdings(CEO/President Jong-Hyun ...
|
Hanmi Pharm far ahead of other pharmas in medicine manufacturingIt was observed Hanmi Pharm has been far ahead of others in the 1st position in medicine manufacturing performance since 2014.
According to the current state of medicine manufa...
|
GSK carries out promotions of personnel to director-level positions in medicine and consumer health business
In order to have continuous growth and accelerate R&D innovation in the medicine, vaccine and consumer healthcare businesses, GSK promoted personnel in a director-level position.
The Korean branch of GSK, which leads...
SFT strongly denounce pharmaceutical companies’ illegal rebates
The Society for the Future of Pharmacists(SFP) pointed out Dong-A Pharm’s illegal rebates, announcing a statement of denunciation about rebate activities of pharmaceutical companies.
Dong-A Pharm was prosecuted for p...
2 products of ‘Amosartan,’ Hanmi’s modified medicines,’ record highest annual manufacturing performance with KRW 57.5 billionThere were 9 products making more than KRW 10 billion last year out of pharmaceutical products approved as incrementally modified drug, and 2 products of Amosartan, Hanmi Pharm’...
|
‘Unchanged’ negative recognition about clinical trials, ‘clinical trial = Maruta’?
In order to study recognition towards clinical trials, the Korea National Enterprise for Clinical Trials(Director Dong-Hyun Ji) revealed a result of the national survey about recognition on clinical trials with 1,000 ...
Korean pharmaceutical market size was KRW 21.7256 trillion last year, increased by 12.9% compared to year before
The last year’s Korean pharmaceutical market was worth of KRW 21.7256 trillion increased by 12.9% compared to the year before, and the manufacturing performance of biologics also exceeded KRW 2 trillion. Moreover, the...
Boryung Pharm’s ‘Kanarb Tab’ recording highest manufacturing performance last year among Korean new drugs
Among pharmaceutical products approved as new drug developed in Korea, a product which recorded the highest sales was ‘Kanarb Tab,’ a Boryung Pharm’s antihypertensive.
In addition, among the 26 new drugs developed in...
Medicine recorded highest manufacturing performance is ‘Gaswhalmyungsu Soln’
A product with the highest manufacturing performance was ‘Gaswhalmyungsu Soln,’ a Dong Wha Pharm’s digestive medicine.
In addition, 5 OTC medicines including Daewoong Pharmaceutical’s Ursa Tab 1mg were researched to...
Hanmi’s women executive ratio reaches 24%, 10 times higher than average of the top Korean companies
The Hanmi Pharm’s women executive ratio reportedly was close to 24%. The ratio is a figure that is 10 times higher than 2.4%, the average of the top 10 Korean large companies(referencing Chaebul.com on 4 April 2017).
...
